Ledger.Open graph →
SEC Form D · Amendment · filed March 1, 2023

SightStream Biotherapeutics, Inc

Offering
$3.5M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Reza Dana · Medfield, MADirectorNick Efstratis · Boise, IDExec · DirectorJason Werner · Medfield, MAExec · DirectorRobert J. Short · Polson, MTDirectorBrad Osborne · Brentwood, TNDirectorDavid Neafus · Medfield, MAExecJean-Bastien Auger · New York, NYExec · DirectorGeorge Mulhern · Boise, IDExecJiagang Zhao · Medfield, MADirectorMike Tobin · New York, NYDirectorChris Popp · New York, NYExecRick Farnell · Boise, IDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗